Ribosomal protein L9 pseudogene 15 (RPL9P15)

RPL9P15 is a processed pseudogene in the human genome derived from the functional ribosomal protein L9 gene (RPL9), which encodes a structural protein component of the 60S large ribosomal subunit in eukaryotic cells[1][2][4]. Pseudogenes like RPL9P15 do not code for functional proteins and, in this case, are not known to have biological functions, disease associations, or drug interactions[1][2][4]. There are multiple ribosomal protein L9 pseudogenes dispersed throughout the human genome, and they are not considered therapeutic targets, biomarkers, or associated with safety concerns in drug discovery or medical literature[1][2][4]. This entry refers specifically to a pseudogene and not a protein, receptor, or enzymatic target. It does not encode a functional protein, and no evidence supports any direct biological role or therapeutic relevance. The canonical functional gene is RPL9 (ribosomal protein L9), with broader biological roles in protein synthesis and some disease associations such as Diamond-Blackfan anemia, but these do not apply to pseudogene 15[2][4]. There is no evidence in the search results of misspelling, but it is not a valid therapeutic target due to its nature as a pseudogene—thus, "is_incorrect" should be true for this context.

Other names

RPL9_4_422RPL9P15